复方阿胶浆对恶性肿瘤化疗增效减毒的临床研究

Clinical research on the reducing toxicity effect of Compound E-jiao Oral Liquid in malignant tumors radiotherapy

目的:观察复方阿胶浆对在恶性肿瘤化疗中的增效减毒作用。方法:经病理学与细胞学诊断为恶性肿瘤住院化疗患者60例,随机分为治疗组(37例)和对照组(23例),两组均按常规的化疗方案进行治疗,治疗组在化疗的同时服用复方阿胶浆,每次40ml,3次/d,连续服用。结果:治疗组和对照组近期疗效率分别为59.4%、34.7%,治疗组生活质量明显高于对照组,化疗过程中治疗组的毒副作用明显低于对照组(P<0.05)。结论:复方阿胶浆能提高恶性肿瘤临床疗效,减少化疗药物的毒副作用,是一种发展前景较好的化疗辅助药物。

Objective：To study the reducing toxicity effect of Compound E-jiao Oral Liquid in malignant tumors radiotherapy.Methods：60 cases of malignant tumor patients to be hospitalized who were diagnosed by pathology and cytology were selected.All patients were divided into two groups：30 patients were treated by Compound E-jiao Oral Liquid and the control group were treated by chemotherapy.Two groups were treated by normal chemotherapy program.The treated group with chemotherapy period continuously took Compound E-jiao Oral Liquid three times every day and 40 ml every time.Results：The recent therapeutic efficiency which were treated and control group were 59.4% and 34.7% respectively.The quality of life of treated group was better than that of control group and toxic effect of treated group was lower than that of the control group（P0.05）.Conclusion：Compound E-jiao Oral Liquid could improve the clinical effect of malignant tumor and reduce toxic effect and is a chemotherapy ancillary drug which has developed prospect.